Literature DB >> 29986784

Pertussis surveillance by small serosurveys of blood donors.

N Kennerknecht1, M Riffelmann1, U Voelker2, C H Wirsing von König3.   

Abstract

Serosurveys have established data about the distribution of immunoglobulin G (IgG)-antibodies to pertussis toxin (PT) in various populations. We tried to detect whether small serosurveys in blood donors could serve as a simple and inexpensive means to collect information about the circulation of Bordetella pertussis. We screened every donation in 307 adult blood donors aged 19-69 years for IgG-anti-PT by standardised enzyme-linked immunosorbent assays (ELISA), and the donors were followed between 2014 and 2016 for a total of 426 person-years. When we used a vertical survey with cut-offs of 100, 62.5 and 40 IU/ml, respectively, as an indicator for recent contacts with B. pertussis, nine (2.9%), 22 (7.2%) and 54 (17.6%) of donors had IgG-anti-PT titres above the respective levels. During the horizontal observation period of 426 person years, six significant increases and two conversions were found, which lead to an estimate of 1878 contacts/100.000 person-years (1.9% per year). Median and mean IgG-anti-PT concentrations remained relatively stable from year to year during the observation period. Our findings show that small serosurveys of blood donors offer a simple and cheap method for the surveillance of B. pertussis.

Entities:  

Keywords:  Blood donors; IgG-anti-PT; pertussis; serosurvey

Mesh:

Substances:

Year:  2018        PMID: 29986784      PMCID: PMC9506697          DOI: 10.1017/S0950268818001851

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   4.434


  16 in total

Review 1.  The role of seroepidemiology in the comprehensive surveillance of vaccine-preventable diseases.

Authors:  Sarah E Wilson; Shelley L Deeks; Todd F Hatchette; Natasha S Crowcroft
Journal:  CMAJ       Date:  2011-11-14       Impact factor: 8.262

2.  Establishment of diagnostic cutoff points for levels of serum antibodies to pertussis toxin, filamentous hemagglutinin, and fimbriae in adolescents and adults in the United States.

Authors:  Andrew L Baughman; Kristine M Bisgard; Kathryn M Edwards; Dalya Guris; Michael D Decker; Kathy Holland; Bruce D Meade; Freyja Lynn
Journal:  Clin Diagn Lab Immunol       Date:  2004-11

Review 3.  Surveillance of pertussis: methods and implementation.

Authors:  Nicole Guiso; Carl Heinz Wirsing von König
Journal:  Expert Rev Anti Infect Ther       Date:  2016-05-31       Impact factor: 5.091

4.  Evaluation of a single-sample serological technique for diagnosing pertussis in unvaccinated children.

Authors:  C H Wirsing von König; D Gounis; S Laukamp; H Bogaerts; H J Schmitt
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1999-05       Impact factor: 3.267

5.  The incidence of Bordetella pertussis infections estimated in the population from a combination of serological surveys.

Authors:  Hester E de Melker; Florens G A Versteegh; Joop F P Schellekens; Peter F M Teunis; Mirjam Kretzschmar
Journal:  J Infect       Date:  2005-12-15       Impact factor: 6.072

6.  [Vaccination coverage in German adults: results of the German Health Interview and Examination Survey for Adults (DEGS1)].

Authors:  C Poethko-Müller; R Schmitz
Journal:  Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz       Date:  2013-05       Impact factor: 1.513

7.  Seroprevalence of pertussis in The Netherlands: evidence for increased circulation of Bordetella pertussis.

Authors:  Sabine C de Greeff; Hester E de Melker; Pieter G M van Gageldonk; Joop F P Schellekens; Fiona R M van der Klis; Liesbeth Mollema; Frits R Mooi; Guy A M Berbers
Journal:  PLoS One       Date:  2010-12-01       Impact factor: 3.240

Review 8.  What to do and what not to do in serological diagnosis of pertussis: recommendations from EU reference laboratories.

Authors:  N Guiso; G Berbers; N K Fry; Q He; M Riffelmann; C H Wirsing von König
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-11-11       Impact factor: 3.267

9.  Pertussis seroprevalence in adults, post-partum women and umbilical cord blood.

Authors:  Aurelia Fallo; Gabriela Manonelles; Daniela Hozbor; Claudia Lara; Miguel Huespe; Silvina Mazzeo; Oscar Canle; Marcelo Galas; Eduardo López
Journal:  Arch Argent Pediatr       Date:  2014-08       Impact factor: 0.694

10.  Under-recognized pertussis in adults from Asian countries: a cross-sectional seroprevalence study in Malaysia, Taiwan and Thailand.

Authors:  M T Koh; C-S Liu; C-H Chiu; W Boonsawat; V Watanaveeradej; N Abdullah; Xh Zhang; R Devadiga; J Chen
Journal:  Epidemiol Infect       Date:  2015-10-15       Impact factor: 2.451

View more
  2 in total

1.  Seroprevalence of Bordetella pertussis toxin antibodies in children and adolescents in Tunis, Tunisia.

Authors:  I Ben Fraj; M Zghal; M Hsairi; A Kechrid; H Smaoui
Journal:  Epidemiol Infect       Date:  2019-01       Impact factor: 2.451

2.  Seroprevalence of pertussis in Madagascar and implications for vaccination.

Authors:  Solohery L Razafimahatratra; Amy Wesolowski; Lala Rafetrarivony; Jean-Michel Heraud; Forrest K Jones; Simon Cauchemez; Richter Razafindratsimandresy; Sandratana J Raharinantoanina; Aina Harimanana; Jean Marc Collard; C J E Metcalf
Journal:  Epidemiol Infect       Date:  2020-11-16       Impact factor: 4.434

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.